At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 11 enrolled
Drug / intervention
Matching Placebo +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-label, Phase 2a Trial to Evaluate the Effect of Escalating Doses of IW-1973 on Tolerability, Endothelial Function, and Hemodynamics in Patients With Stable Type 2 Diabetes and Hypertension
In Brief
A Phase 2 clinical trial evaluating Matching Placebo and IW-1973 for Diabetes Mellitus, Type 2 and Hypertension. Completed, enrolled 11 participants across 1 site.
Detailed Summary
To evaluate the impact of escalating doses of IW-1973 on endothelial function \[using EndoPAT to measure fingertip small vessel pulse volume\], blood pressure (BP), and heart rate.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2, Hypertension
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartSep 2016
First PostedSep 2016
Primary CompletionMar 2017
TodayJul 2026
First PostedSep 20, 2016
Enrollment StartSep 1, 2016
Primary CompletionMar 17, 2017
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 9.8 years ago
Interventions
Matching Placebodrug
IW-1973drug